MedTrace Logo

Study of Affective Forecasting Skills in Post-traumatic Stress Disorder

NCT05268965 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 97

Last updated 2025-12-05

No results posted yet for this study

Summary

Post-traumatic stress disorder (PTSD) is associated with a marked tendency to have exaggerated and persistent negative beliefs and expectations about oneself or the world . Although posttraumatic stress symptoms have been shown to be associated with a tendency to negatively anticipate the future, affective forecasting skills (i.e., the ability to predict one's own emotional reactions in response to a future event) have never been explored in PTSD . The hypothesis that the PTSD is associated with a negative affective forecasting bias, characterized by a tendency to predict more intense emotional responses to future negative events.

Conditions

  • Post-traumatic Stress Disorder

Interventions

BEHAVIORAL

Experimental: group comparison

* Standardized psychiatric interview (Mini International Neuropsychiatric Interview MINI) * State-Trait-Anxiety Inventory (Spielberger, 1993) * Beck Depression Inventory (BDI-II, 1998) * Cognitive Emotional Regulation Questionnaire (Jermann \& al., 2006) Participant installation and testing: 2 stages (forecasting on a computer, and exposure in virtual reality) Task / affective forecasting: * Step 1: forecasting about one's own emotional responses regarding pleasant, neutral and unpleasant scenarios * Step 2: experience of the same scenarios in virtual reality

Sponsors & Collaborators

  • University Hospital, Lille

    lead OTHER

Principal Investigators

  • Guillaume Vaiva, MD,PhD · University Hospital, Lille

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-02-28
Primary Completion
2023-11-22
Completion
2023-11-22

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05268965 on ClinicalTrials.gov